Financial Impact of Treatment Choice in Chronic Myeloid Leukemia

That is the title of a recent paper out in ClinicoEconomics and Outcomes Research with co-authors Jennifer Vaughn, Nadine Zawadzki, Shurui Zhang, Paul Pinkston, and David Wei. The subtitle is A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives. The abstract is below: Purpose: To evaluate the financial impact of treating CML…

Read More

Why the Future of IDR Depends on Smarter Technology

Focusing on fringe cases of abuse misses a more immediate and arguably more pervasive problem: many provider organizations are not getting the access to IDR they’re entitled to because the process is too difficult to navigate effectively at scale.  The post Why the Future of IDR Depends on Smarter Technology appeared first on MedCity News.

Read More